Dmytro Kharkov

Ben Lamm: Colossal appoints Andrew Pask as Chief Biology Officer

Ben Lamm: Colossal appoints Andrew Pask as Chief Biology Officer
@BenLamm: Colossal appoints Andrew Pask

Colossal, a biotechnology company, formally launched its operations in Australia.

Ben Lamm, co-founder of Colossal, announced the appointment of Andrew Pask as the company's new Chief Biology Officer. Pask, known for his extensive expertise in developmental genetics, has been brought on board to advance Colossal's ambitious projects in de-extinction and conservation biology. According to Lamm, ''bringing Andrew onto the team represents a significant step forward in our pursuit to achieve groundbreaking scientific outcomes.'' Colossal's entrance into the Australian market and the strategic hiring of Pask underscore the company's commitment to innovative biological research.

(no output)

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.